Until we see each other again,
Merck Diabetes and Hypertension Awards to be rolled out in African and Asian Universities as part of Merck Capacity Advancement Program
April 18, 2016April 18, 2016 | | 0 Comment | 7:02 am
Merck Announces the winner of Merck Diabetes Award for UAE
· Merck announces the winner of Merck Diabetes Award for UAE
· Merck Diabetes Award will be rolled out in 30 African and Asian Universities; aims to create a platform for Diabetes experts across the continents.
· Merck supports Diabetes education and community awareness through its Merck Capacity Advancement Program.
In April 2016; Merck Capacity Advancement Program recognized the World Health Day by launching the “Merck Diabetes Award and Merck Hypertension Awards” across more than 30 African and Asian universities with the aim of building for platform of Diabetes and hypertension experts across the globe.
In February 2015, Merck in partnership with Dubai Medical University invited all medical students to apply for “Merck Diabetes Award” 2016 with the theme – “Every Day is a Diabetes Day.”
Today Merck announces the winner who will receive the award in a big ceremony attended by Merck Health care CEO, The Dean of Dubai Medical University, President of International Diabetes Federation (IDF) Africa, Vice President of Pan-African Cardiology Society and the director of NCDs of Indonesia Ministry of Health.
The students across African and Asian medical universities were asked to submit a concept paper aiming to improve the awareness about Diabetes early detection and prevention in their countries and to encourage their society, scientific community, local authorities, media and relevant stakeholders to think and act on Diabetes Every Day. The winner from each university will be awarded a one year postgraduate Diabetes Diploma.
Merck has decided to kick off its Hypertension Award for the same university with the theme “What the Health Heart needs”, the winner of this award will receive a one year Postgraduate Preventive Cardiovascular Medicines in South Wales University.
”Merck plays an important role in building healthcare capacity Africa addressing Non Communicable Diseases(NCDs) focusing on rural areas, medical students and local partnership with Academia, Ministries of Health, policy makers and governments,” Belen Garijo, CEO of Merck Healthcare and Member of The Executive Board of Merck highlighted.
Dr Dima Abd Elmannan, Clinical Dean of Dubai Medical Colleges emphasized, “In recent years, we have seen a rapid rise in type 2 diabetes across all age groups. The UAE is ranked 16th worldwide, with 19.2% of the UAE population living with diabetes. These statistics indicate that the region has high risk factors for diabetes, mostly related to rising obesity rates and physical inactivity. Therefore, there is an urgent need to develop accredited teaching programs and encourage people and relevant stakeholders to think and act on diabetes every day. I am sure Merck Diabetes Award will encourage our medical students to be creative in developing new strategies, policies and programs to encourage community members to think about diabetes every day.”
“We’re excited about the medical students’ application for Merck Diabetes Awards; most of their ideas were very innovative and can make a change in Diabetes landscape in UAE. The scientific committee decided to give the award to two applicants, the first winner was Nujood Al Shirawi, a graduate if Dubai medical University and currently intern house officer under Dubai Health authority (DHA). The second prize was granted to applications submitted by two medical students in the 4th year of Dubai Medical University, Sana Laraib Daud and Zoubia Fathima.” Dr. Ahmed Reja, the President of IDF Africa and President of Ethiopia Diabetes Association and Chief of endocrinology at Black Lion Hospital said.
“We are very happy to partner with Merck to drive their strategy to build diabetes capacity and roll out the Merck Diabetes Award across the continent. The outcome in UAE was remarkable, it encouraged the students to be more innovative and take a leadership position to fight Diabetes in their own country,” Dr. Ahmed Reja added.
“We are happy to partner with Merck to implement their Capacity Advancement Program focusing on Hypertension in 2016. Thiscombined Diabetes and Hypertension education program will contribute towards providing guidelines and clinical practice for prevention, diagnosis and management of those diseases and their complications. The objective of this initiative is to increase the level of knowledge for medical students who will work in the near future with patients to help them prevent, understand and control their diseases across the continent.” Prof. Elijah Ogola, Vice President of Pan-African Cardiology Society said during the event.
Merck Diabetes and Hypertension Awards marks another step in our commitment to working with Governments, Academia and relevant stakeholders in building healthcare capacity with a focus on non-communicable diseases in various countries in Asia-Pacific, Middle East, Africa and Latin America.” Rasha Kelej, Merck Chief Social Officer added.
About the Merck Capacity Advancement Program (CAP)
Merck CAP is a 5-year program aiming to expand the professional capacity in developing countries in the areas of research and development, advocacy building, supply-chain integrity and efficiency, pharmacovigilance, medical education, and community awareness.
As part of the CAP, in 2015, more than 9,000 medical students in partnership with African Universities such as University of Nairobi, Makerere University, Namibia University and University of Ghana. In addition, Asian universities such as Maharashtra University, India and University of Indonesia will all benefit from European-accredited clinical chronic diseases management training, which seeks to equip them with skills to better manage and prevent these diseases.
Merck is planning to target more than 25,000 students by the end of 2018 expanding to more African, Asian, Latin American and Middle Eastern countries with special focus on non–communicable diseases such as diabetes, cancer and fertility management. The program will also kick off initiatives on building research capacity and improving supply chain in order to improve patient safety in Africa.